Part III. The pathobiology of ductal carcinoma in situ (Q33987012)

30 July 2017

1 reference

title

Part III. The pathobiology of ductal carcinoma in situ (English)

1 reference

30 July 2017

1 reference

Catzavelos C

1 reference

30 July 2017

language of work or name

1 reference

1 May 2000

1 reference

Current Problems in Cancer

30 July 2017

published in

1 reference

30 July 2017

1 reference

30 July 2017

1 reference

30 July 2017

page(s)

125-140

1 reference

Carcinoma in situ of the breast

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990014-X

7 January 2021

Duct carcinoma in situ. Relationship of extent of noninvasive disease to the frequency of occult invasion, multicentricity, lymph node metastases, and short-term treatment failures

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990014-X

7 January 2021

Intraductal carcinoma of the breast (208 cases). Clinical factors influencing treatment choice

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990014-X

7 January 2021

Extent, distribution, and mammographic/histological correlations of breast ductal carcinoma in situ

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990014-X

7 January 2021

Intraductal extension of primary invasive breast carcinoma treated by breast-conservative surgery. Computer graphic three-dimensional reconstruction of the mammary duct-lobular systems

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990014-X

7 January 2021

Screening-detected and symptomatic ductal carcinoma in situ: mammographic features with pathologic correlation

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990014-X

7 January 2021

Re-excision operations in nonpalpable breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990014-X

7 January 2021

Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990014-X

7 January 2021

Fifteen-year results of breast-conserving surgery and definitive breast irradiation for the treatment of ductal carcinoma in situ of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990014-X

7 January 2021

Relationship Between the Size and Margin Status of Ductal Carcinoma In Situ of the Breast and Residual Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990014-X

7 January 2021

Follow-up of two treatment modalities for ductal cancer in situ of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990014-X

7 January 2021

Ductal carcinoma in situ of the breast: a surgeon's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990014-X

7 January 2021

The influence of margin width on local control of ductal carcinoma in situ of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990014-X

7 January 2021

Prognostic classification of breast ductal carcinoma-in-situ

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990014-X

7 January 2021

Noninvasive ductal carcinoma of the breast: the relevance of histologic categorization

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990014-X

7 January 2021

Duct carcinoma in situ. Pathology and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990014-X

7 January 2021

Ductal carcinoma in situ of the breast. Heterogeneity of individual lesions.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990014-X

7 January 2021

A critical appraisal of six modern classifications of ductal carcinoma in situ of the breast (DCIS): correlation with grade of associated invasive carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990014-X

7 January 2021

Ductal carcinoma in situ of the breast: Reproducibility of histological subtype analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990014-X

7 January 2021

Consistency achieved by 23 European pathologists from 12 countries in diagnosing breast disease and reporting prognostic features of carcinomas. European Commission Working Group on Breast Screening Pathology

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990014-X

7 January 2021

Ten-year results of breast-conserving surgery and definitive irradiation for intraductal carcinoma (ductal carcinoma in situ) of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990014-X

7 January 2021

Ductal carcinoma in situ (intraductal carcinoma) of the breast treated with breast-conserving surgery and definitive irradiation. Correlation of pathologic parameters with outcome of treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990014-X

7 January 2021

Duct carcinoma in situ: 227 cases without microinvasion

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990014-X

7 January 2021

Atypical hyperplastic lesions of the female breast. A long-term follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990014-X

7 January 2021

Risk factors for breast cancer in women with proliferative breast disease

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990014-X

7 January 2021

Molecular genetic studies of early breast cancer evolution

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990014-X

7 January 2021

Analysis of loss of heterozygosity in 399 premalignant breast lesions at 15 genetic loci

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990014-X

7 January 2021

Loss of heterozygosity in ductal carcinoma in situ of the breast.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990014-X

7 January 2021

Atypical ductal hyperplasia of the breast: clonal proliferation with loss of heterozygosity on chromosomes 16q and 17p.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990014-X

7 January 2021

Characterization of extensive genetic alterations in ductal carcinoma in situ by fluorescence in situ hybridization and molecular analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990014-X

7 January 2021

p53 mutations and c-erbB-2 amplification in intraductal and invasive breast carcinomas of high histologic grade.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990014-X

7 January 2021

Intratumoral heterogeneity in breast carcinoma revealed by laser-microdissection and comparative genomic hybridization

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990014-X

7 January 2021

Genetic alterations on chromosome 16 and 17 are important features of ductal carcinoma in situ of the breast and are associated with histologic type

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990014-X

7 January 2021

Biophenotypes of breast carcinoma in situ defined by image analysis of biological parameters

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990014-X

7 January 2021

Immunohistochemical determination of estrogen and progesterone receptors in human breast carcinoma. Correlation with histopathology and DNA flow cytometry

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990014-X

7 January 2021

Oestrogen receptors in benign epithelial lesions and intraduct carcinomas of the breast: an immunohistological study

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990014-X

7 January 2021

Potential value of hormone receptor assay in carcinoma in situ of breast

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990014-X

7 January 2021

Oestrogen receptor expression in ductal carcinoma in situ of the breast: relationship to flow cytometric analysis of DNA and expression of the c-erbB-2 oncoprotein.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990014-X

7 January 2021

Ductal carcinoma in situ of the breast. Histologic categorization and its relationship to ploidy and immunohistochemical expression of hormone receptors, p53, and c-erbB-2 protein

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990014-X

7 January 2021

Loss of heterozygosity on chromosome 11p15 during histological progression in microdissected ductal carcinoma of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990014-X

7 January 2021

Overexpression of HER-2/neu and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990014-X

7 January 2021

Intraductal carcinoma of the breast: Follow-up after biopsy only

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990014-X

7 January 2021

Continued local recurrence of carcinoma 15-25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990014-X

7 January 2021

Heterogeneity of intraductal carcinoma of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990014-X

7 January 2021

ECM and Cell Surface Proteolysis: Regulating Cellular Ecology

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990014-X

7 January 2021

Cadherins: a molecular family important in selective cell-cell adhesion

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990014-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990014-X

1 reference

7 January 2021

Expression of HGF/SF, HGF1/MSP, and c-met suggests new functions during early chick development

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990014-X

7 January 2021

Immunohistochemical localization of urokinase-type plasminogen activator, type-1 plasminogen-activator inhibitor, urokinase receptor and alpha(2)-macroglobulin receptor in human breast carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990014-X

7 January 2021

Cellular localization of urokinase-type plasminogen activator, its inhibitors, and their mRNAs in breast cancer tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990014-X

7 January 2021

Immunohistochemical localization of matrix metalloproteinase 2 and its specific inhibitor TIMP-2 in neoplastic tissues with monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990014-X

7 January 2021

Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990014-X

7 January 2021

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990014-X

7 January 2021

Halting angiogenesis suppresses carcinoma cell invasion

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990014-X

7 January 2021

Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990014-X

7 January 2021

Angiogenesis and inflammation in ductal carcinoma in situ of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990014-X

7 January 2021

Distinct angiogenic patterns are associated with high-grade in situ ductal carcinomas of the breast.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990014-X

7 January 2021

Vascular permeability factor (Vascular endothelial growth factor) expression and angiogenesis in patients with ductal carcinoma in situ of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2800%2990014-X

7 January 2021

10.1016/S0147-0272(00)90014-X

Identifiers

DOI

1 reference

30 July 2017

1 reference